Lonza | LONN - Net Income

Stock Price
474.00
Daily Change
-8.70 -1.80%
Monthly
-4.90%
Yearly
-19.47%
Q2 Forecast
470.40

Lonza reported CHF426M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Akzo Nobel EUR 93M 505M Mar/2026
Alcon AG USD 217M 20M Dec/2025
Almirall EUR 19.58M 7M Dec/2025
AstraZeneca USD 3.08B 754M Mar/2026
BASF EUR 560M 388M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Beiersdorf EUR 387M 165M Dec/2025
Covestro EUR -378M 331M Dec/2025
Demant DKK 427M 690M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Geberit CHF 103.5M 52.3M Dec/2025
Genmab DKK 31M 370M Dec/2025
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
GN Store Nord DKK 344M 271M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Johnson Matthey GBP -18M 93M Dec/2025
Merck EUR 319M 583M Dec/2025
Novartis USD 3.16B 747M Mar/2026
Philips EUR 395M 211M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
Sika AG CHF 490.2M 63.6M Dec/2025
Smith & Nephew USD 293M 79M Dec/2025
Solvay EUR -95M 129M Dec/2025
UCB EUR 1.08B 608M Dec/2025